1887

Abstract

Infection with hepatitis delta virus (HDV) always occurs in association with hepatitis B virus (HBV) and is a cause of significant morbidity and mortality. We present a case of severe acute HDV infection superimposed on a previously unrecognized HBV infection, in which an interferon-sparing antiviral therapy consisting of tenofovir disoproxil fumarate (TDF) and lamivudine was initiated and subsequently maintained. Evidence of successful suppression of HDV ribonucleic acid (RNA) was obtained after 65 weeks of TDF-based treatment. This was mirrored by a significant reduction in the levels of HBV DNA and HBV surface antigen. HDV RNA subsequently rebounded after our patient stopped antiviral therapy of his own accord. Interferon-sparing TDF-based antiviral therapy was safe and effective in achieving HDV RNA suppression in acute HDV superinfection. Further research into the utility of interferon-sparing TDF-based regimes in the treatment of acute HDV infection is needed.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.046649-0
2012-12-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/12/1780.html?itemId=/content/journal/jmm/10.1099/jmm.0.046649-0&mimeType=html&fmt=ahah

References

  1. Bichko V., Netter H. J., Wu T. T., Taylor J.. ( 1994;). Pathogenesis associated with replication of hepatitis delta virus. . Infect Agents Dis 3:, 94–97.[PubMed]
    [Google Scholar]
  2. Casey J. L., Brown T. L., Colan E. J., Wignall F. S., Gerin J. L.. ( 1993;). A genotype of hepatitis D virus that occurs in northern South America. . Proc Natl Acad Sci U S A 90:, 9016–9020. [CrossRef][PubMed]
    [Google Scholar]
  3. Hedin G., Weiland O., Ljunggren K., Strömberg A., Nordenfelt E., Hansson B. G., Oberg B.. ( 1987;). Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet. . Prog Clin Biol Res 234:, 309–320.[PubMed]
    [Google Scholar]
  4. Lau D. T., Doo E., Park Y., Kleiner D. E., Schmid P., Kuhns M. C., Hoofnagle J. H.. ( 1999;). Lamivudine for chronic delta hepatitis. . Hepatology 30:, 546–549. [CrossRef][PubMed]
    [Google Scholar]
  5. Le Gal F., Gault E., Ripault M. P., Serpaggi J., Trinchet J. C., Gordien E., Dény P.. ( 2006;). Eighth major clade for hepatitis delta virus. . Emerg Infect Dis 12:, 1447–1450. [CrossRef][PubMed]
    [Google Scholar]
  6. Mansour W., Ducancelle A., Le Gal F., Le Guillou-Guillemette H., Abgueguen P., Pivert A., Calès P., Gordien E., Lunel F.. ( 2010;). Resolution of chronic hepatitis delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. . J Clin Virol 47:, 97–99. [CrossRef][PubMed]
    [Google Scholar]
  7. Niro G. A., Ciancio A., Tillman H. L., Lagget M., Olivero A., Perri F., Fontana R., Little N., Campbell F.. & other authors ( 2005;). Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. . Aliment Pharmacol Ther 22:, 227–232. [CrossRef][PubMed]
    [Google Scholar]
  8. Niro G. A., Ciancio A., Gaeta G. B., Smedile A., Marrone A., Olivero A., Stanzione M., David E., Brancaccio G.. & other authors ( 2006;). Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. . Hepatology 44:, 713–720. [CrossRef][PubMed]
    [Google Scholar]
  9. Rasshofer R., Choi S., Wölfl P., Manneck K., Weisensee U., Roggendorf M.. ( 1990;). Inhibition of HDV RNA replication in vitro by ribavirin and suramin. . In Viral Hepatitis and Liver Disease, pp. 659–662. Edited by Hollinger F., Lemon S., Margolis H... Baltimore:: Williams & Wilkins;.
    [Google Scholar]
  10. Sheldon J., Ramos B., Toro C., Ríos P., Martínez-Alarcón J., Bottecchia M., Romero M., Garcia-Samaniego J., Soriano V.. ( 2008;). Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?. Antivir Ther 13:, 97–102.[PubMed]
    [Google Scholar]
  11. Smedile A., Dentico P., Zanetti A., Sagnelli E., Nordenfelt E., Actis G. C., Rizzetto M.. ( 1981;). Infection with the delta agent in chronic HBsAg carriers. . Gastroenterology 81:, 992–997.[PubMed]
    [Google Scholar]
  12. Smedile A., Farci P., Verme G., Caredda F., Cargnel A., Caporaso N., Dentico P., Trepo C., Opolon P.. & other authors ( 1982;). Influence of delta infection on severity of hepatitis B. . Lancet 2:, 945–947. [CrossRef][PubMed]
    [Google Scholar]
  13. Smedile A., Rosina F., Saracco G., Chiaberge E., Lattore V., Fabiano A., Brunetto M. R., Verme G., Rizzetto M., Bonino F.. ( 1991;). Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. . Hepatology 13:, 413–416. [CrossRef][PubMed]
    [Google Scholar]
  14. Tang J. R., Hantz O., Vitvitski L., Lamelin J. P., Parana R., Cova L., Lesbordes J. L., Trépo C.. ( 1993;). Discovery of a novel point mutation changing the HDAg expression of a hepatitis delta virus isolate from Central African Republic. . J Gen Virol 74:, 1827–1835. [CrossRef][PubMed]
    [Google Scholar]
  15. Wedemeyer H., Yurdaydìn C., Dalekos G. N., Erhardt A., Çakaloğlu Y., Değertekin H., Gürel S., Zeuzem S., Zachou K.. & other authors ( 2011;). Peginterferon plus adefovir versus either drug alone for hepatitis delta. . N Engl J Med 364:, 322–331. [CrossRef][PubMed]
    [Google Scholar]
  16. Williams V., Brichler S., Radjef N., Lebon P., Goffard A., Hober D., Fagard R., Kremsdorf D., Dény P., Gordien E.. ( 2009;). Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. . J Gen Virol 90:, 2759–2767. [CrossRef][PubMed]
    [Google Scholar]
  17. Wolters L. M., van Nunen A. B., Honkoop P., Vossen A. C., Niesters H. G., Zondervan P. E., de Man R. A.. ( 2000;). Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. . J Viral Hepat 7:, 428–434. [CrossRef][PubMed]
    [Google Scholar]
  18. Yurdaydin C., Bozkaya H., Onder F. O., Sentürk H., Karaaslan H., Akdoğan M., Cetinkaya H., Erden E., Erkan-Esin O.. & other authors ( 2008;). Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. . J Viral Hepat 15:, 314–321. [CrossRef][PubMed]
    [Google Scholar]
  19. Yurdaydın C., Idilman R., Bozkaya H., Bozdayi A. M.. ( 2010;). Natural history and treatment of chronic delta hepatitis. . J Viral Hepat 17:, 749–756. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.046649-0
Loading
/content/journal/jmm/10.1099/jmm.0.046649-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error